Garcia JA - Search Results

1

HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer.

Hearn JWD, Sweeney CJ, Almassi N, Reichard CA, Reddy CA, Li H, Hobbs B, Jarrard DF, Chen YH, Dreicer R, Garcia JA, Carducci MA, DiPaola RS, Sharifi N. Hearn JWD, et al. Among authors: garcia ja. JAMA Oncol. 2020 Apr 1;6(4):e196496. doi: 10.1001/jamaoncol.2019.6496. Epub 2020 Apr 9. JAMA Oncol. 2020. PMID: 32053149 Free PMC article. Clinical Trial.

2

PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.

Ciezki JP, Reddy CA, Garcia J, Angermeier K, Ulchaker J, Mahadevan A, Chehade N, Altman A, Klein EA. Ciezki JP, et al. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):512-7. doi: 10.1016/j.ijrobp.2005.07.960. Epub 2005 Oct 6. Int J Radiat Oncol Biol Phys. 2006. PMID: 16213667

3

Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies.

Garcia JA, Dreicer R. Garcia JA, et al. Nat Clin Pract Urol. 2005 Jan;2(1):32-7. doi: 10.1038/ncpuro0068. Nat Clin Pract Urol. 2005. PMID: 16474574 Review.

4

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Among authors: garcia ja. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

5

Systemic chemotherapy for advanced bladder cancer: update and controversies.

Garcia JA, Dreicer R. Garcia JA, et al. J Clin Oncol. 2006 Dec 10;24(35):5545-51. doi: 10.1200/JCO.2006.08.0564. J Clin Oncol. 2006. PMID: 17158540 Review.

6

Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.

Rini BI, Tamaskar I, Shaheen P, Salas R, Garcia J, Wood L, Reddy S, Dreicer R, Bukowski RM. Rini BI, et al. J Natl Cancer Inst. 2007 Jan 3;99(1):81-3. doi: 10.1093/jnci/djk008. J Natl Cancer Inst. 2007. PMID: 17202116

7

Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib.

Tamaskar I, Bukowski R, Elson P, Ioachimescu AG, Wood L, Dreicer R, Mekhail T, Garcia J, Rini BI. Tamaskar I, et al. Ann Oncol. 2008 Feb;19(2):265-8. doi: 10.1093/annonc/mdm483. Epub 2007 Oct 24. Ann Oncol. 2008. PMID: 17962201 Free article.

8

Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.

Tamaskar I, Garcia JA, Elson P, Wood L, Mekhail T, Dreicer R, Rini BI, Bukowski RM. Tamaskar I, et al. Among authors: garcia ja. J Urol. 2008 Jan;179(1):81-6; discussion 86. doi: 10.1016/j.juro.2007.08.127. Epub 2007 Nov 12. J Urol. 2008. PMID: 17997441

9

Clinical and biological effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate carcinoma.

Garcia JA, Klein EA, Magi-Galluzzi C, Elson P, Triozzi P, Dreicer R. Garcia JA, et al. Clin Cancer Res. 2008 May 15;14(10):3052-9. doi: 10.1158/1078-0432.CCR-07-4731. Clin Cancer Res. 2008. PMID: 18483371 Clinical Trial.

10

Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma.

Rini BI, Choueiri TK, Elson P, Khasawneh MK, Cotta C, Unnithan J, Wood L, Mekhail T, Garcia J, Dreicer R, Bukowski RM. Rini BI, et al. Cancer. 2008 Sep 15;113(6):1309-14. doi: 10.1002/cncr.23711. Cancer. 2008. PMID: 18618496 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,104 results

Search Page